Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna
Abstract
The invention relates generally by in-situ recombinant method of activated the gene or expression of the gene expression. The invention further relates generally wherein the endogenous gene is higher than the level of the normal cell is represented by to conduct expression in a cell method. A separate an embodiment of the invention, wherein the expression of the cell, is activated the endogenous gene expression of the gene expression one of said control series's the regulatory sequence non-homology or the recombinant illegal; An or improving the expression of the gene endogenous. The other of solution, one or more to marker is selected by the integrated on the expression carrier the copy number of at more than one or according to of the label, that further improving to the expression of the gene endogenous. The invention furthermore provide the identification and expressing a method for the gene of the technology unable to discover use of a, the integrated without target sequence. The invention also provides a separation of coding of the protein the nucleic acid molecule (of the cDNA molecule), and separable energy of such a it is a transverse heterologous protein film of the protein the method for cell. The present invention also relates to the isolated gene and gene product associated nucleic acid molecule and containing the gene and gene product associated nucleic acid molecule, wherein the composition can be used for more and treatments for diagnosis. Therefore, the invention, wherein the activated and separating the endogenous gene, comprising a layer of human growth and related gene, and does not need to any wherein the gene of the sequences, structures, function or the expression.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
69 members in 17 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 94122397 | United States of America | A | |
| 15964398 | United States of America | A | |
| 9820094 | United States of America | W |
Members69
| Document | Office | Kind | |
|---|---|---|---|
| ZA988795B | South Africa | B | |
| CA2304642A1 | Canada | A1 | |
| WO9915650A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU9581698A | Australia | A | |
| NO20001497D0 | Norway | D0 | |
| NO20001497L | Norway | L | |
| EP1017803A1 | European Patent Office (EPO) | A1 | |
| CA2364267A1 | Canada | A1 | |
| WO0049162A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU3003700A | Australia | A | |
| WO9915650A9 | World Intellectual Property Organization (WIPO) | A9 | |
| WO0049162A3 | World Intellectual Property Organization (WIPO) | A3 | |
| HK1027375A | Hong Kong, China | A | |
| HK1027375A1 | Hong Kong, China | A1 | |
| CN1280615A | China | A | |
| WO0049162A8 | World Intellectual Property Organization (WIPO) | A8 | |
| KR20010024296A | Republic of Korea | A | |
| IL135242A0 | Israel | A0 | |
| IL135242D0 | Israel | D0 | |
| EP1155131A2 | European Patent Office (EPO) | A2 | |
| BR9812540A | Brazil | A | |
| EP1017803A4 | European Patent Office (EPO) | A4 | |
| US6361972B1 | United States of America | B1 | |
| HK1040095A1 | Hong Kong, China | A1 | |
| US6410266B1 | United States of America | B1 | |
| IL144960A0 | Israel | A0 | |
| IL144960D0 | Israel | D0 | |
| AU750025B2 | Australia | B2 | |
| CN1384881A | China | A | |
| US6524818B1 | United States of America | B1 | |
| US6524824B1 | United States of America | B1 | |
| NZ504185A | New Zealand | A | |
| US6541221B1 | United States of America | B1 | |
| ZA200106777B | South Africa | B | |
| US6602686B1 | United States of America | B1 | |
| BR0008313A | Brazil | A | |
| US6623958B1 | United States of America | B1 | |
| US2003180267A1 | United States of America | A1 | |
| JP2003535564A | Japan | A | |
| US6670185B1 | United States of America | B1 | |
| JP2004501601A | Japan | A | |
| US6740503B1 | United States of America | B1 | |
| US2004162416A1 | United States of America | A1 | |
| US6897066B1 | United States of America | B1 | |
| US7033782B2 | United States of America | B2 | |
| US2006105318A1 | United States of America | A1 | |
| US2007111280A1 | United States of America | A1 | |
| US2007122391A1 | United States of America | A1 | |
| US2007178585A1 | United States of America | A1 | |
| US7316923B1 | United States of America | B1 | |
| EP1155131B1 | European Patent Office (EPO) | B1 | |
| AT402264T | Austria | T | |
| ATE402264T1 | Austria | T1 | |
| US7419828B2 | United States of America | B2 | |
| DE60039585D1 | Germany | D1 | |
| US7569220B2 | United States of America | B2 | |
| US2010010196A1 | United States of America | A1 | |
| CN100582230C | China | C | |
| EP1017803B1 | European Patent Office (EPO) | B1 | |
| AT471373TThis record | Austria | T | |
| ATE471373T1 | Austria | T1 | |
| DE69841723D1 | Germany | D1 | |
| DK1017803T3 | Denmark | T3 | |
| US7785831B2 | United States of America | B2 | |
| US7842792B2 | United States of America | B2 | |
| IL135242A | Israel | A | |
| US2011217779A1 | United States of America | A1 | |
| JP5377806B2 | Japan | B2 | |
| CA2304642C | Canada | C |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 98949508
Titles2
- German
- EXPRESSION VON ENDOGENEN GENEN DURCH HOMOLOGE REKOMBINATION EINES VEKTORKONSTRUKTES MIT ZELLULÄRER DNA
- English
- EXPRESSION OF ENDOGENIC GENES THROUGH HOMOLOGOUS RECOMBINATION OF A VECTOR CONSTRUCT WITH CELLULAR DNA
Classification
- CPC, 7
- C12N15/90
- C12N15/63
- A61K48/00
- C12N15/67
- C12N15/85
- C12N2840/20
- C12N2840/44
- IPC, 14
- C12N15 09
- C12N15 11
- A61K48 00
- C12N1 15
- C12N1 19
- C12N1 21
- C12N5 10
- C12N15 00
- C12N15 63
- C12N15 67
- C12N15 85
- C12N15 86
- C12N15 90
- C12P21 00